Release Date: 16/08/11 17:09 Summary: Response to ASX Query - Appendix 5B Price Sensitive: Yes Download Document 83.21KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%